1245628

Eidos Therapeutics, Inc. — FEI 3019382117

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Francisco, CA (United States)

Additional Details

Sponsor, Contract Research Organization